市场调查报告书
商品编码
1540896
2024-2032 年按技术、动物类型、感染类型、最终用户和地区分類的兽医传染病诊断市场报告Veterinary Infectious Disease Diagnostics Market Report by Technology, Animal Type, Infection Type, End User, and Region 2024-2032 |
2023年,全球IMARC Group传染病诊断市场规模达20亿美元。宠物和牲畜疾病盛行率的增加、宠物主人意识的提高、技术的进步、准确诊断的需要、先进工具的采用、宠物健康问题的加剧、兽医基础设施的扩大、政府预防人畜共患疾病的倡议以及研究经费的增加都是因素推动市场成长。
主要市场驱动因素:在全球范围内,人畜共通传染病的盛行率不断上升,大大增加了对先进诊断解决方案的需求,为市场创造了积极的前景。此外,政府对动物保健的措施和资金的增加正在推动兽医传染病诊断市场的成长。此外,畜牧业的扩张以及主要参与者不断升级的研发(R&D)活动倡议正在推动市场成长。此外,护理点 (POC) 诊断的使用不断增加、兽医护理中远距医疗的使用不断增长,以及消费者对动物福利和品质标准的认识不断提高,这些都进一步推动了兽医传染病诊断的需求。
主要市场趋势:由于分子诊断具有卓越的敏感性和特异性,人们对分子诊断的偏好发生了转变,这是主要市场趋势之一。此外,由于可以现场操作,用于诊断的成簇规则间隔短回文重复序列(CRISPR)的大量使用是促进市场成长的另一个因素。此外,人工智慧(AI)和机器学习(ML)的不断融合,特别是在诊断工具中,以产生更准确的结果,正在培育积极的兽医传染病诊断市场前景。与此一致的是,对伴侣动物的需求不断增加,以及逐渐转向同时检测多种病原体的多重诊断检测,正在推动市场的成长。此外,兽医实践和诊断实验室之间的合作以及对即时(POC)诊断解决方案不断增长的需求正在推动市场向前发展。
地理趋势:根据兽医传染病诊断市场预测,北美由于先进的医疗基础设施、宠物拥有量的增加以及动物健康投资的迅速增长而引领市场。此外,主要参与者对研发(R&D)的日益关注以及有利的政府政策正在支持区域市场的成长。由于严格的动物卫生法规和许多主要市场参与者的存在,欧洲在市场上占有相当大的份额。此外,在亚太地区,人们对动物健康意识的不断增强、传染病诊断的便利性以及政府对动物健康的资助不断增加,正在加速市场的成长。
竞争格局:兽医传染病诊断行业的一些主要市场参与者包括 Abbott Laboratories、Biomerieux SA、Creative Diagnostics、HESKA Corporation、Innovative Diagnostics、IDEXX Laboratories Inc.、Neogen Corporation、Qiagen NV、Randox Laboratories Ltd、Thermo Fisher Scientific Inc、rmo Fisher Scientific Inc、rmo Fisher Scientific Inc、rmo Fisher Scientific Inc、rmo Fisher Scientific Inc、rmo Fisher Scientific Inc、维克等。
挑战与机会:根据兽医传染病诊断市场报告,诊断工具的成本不断上升是阻碍市场成长的主要因素之一。此外,监管障碍和复杂的审批流程给市场参与者带来了各种挑战,这是限制市场成长的另一个因素。然而,市场也提供了各种机会,例如动物传染病的日益普及和宠物饲养量的增加正在建立对先进诊断的巨大需求。此外,技术的快速发展,包括方便易用的诊断设备的出现以及对兽医健康和福利的日益关注,都是大大推动兽医传染病诊断市场收入的因素。
宠物和牲畜传染病的盛行率不断上升
宠物和牲畜传染病的流行正在加速市场的成长。例如,猫白血病病毒 (FeLV) 是猫最常见的传染病之一,影响美国和加拿大 2-3% 的猫科动物。宠物和人类之间的互动激增进一步放大了这种风险,从而进一步增加了疾病传播的机会。此外,快速的城市化、畜牧业实践的变化以及确诊患者数量的增加正在支持市场的成长。推动兽医传染病诊断市场价值的另一个因素是对准确及时诊断的需求不断增长,这有助于有效控制和遏制这些疾病。
提高宠物主人的意识
宠物主人对早期疾病检测重要性的认识不断提高是推动市场成长的关键因素。随着宠物被视为不可分割的家庭成员,主人越来越重视它们的健康和福祉。这种意识的提高导致对定期健康检查、预防措施和早期诊断测试的需求不断增长。此外,先进诊断工具和技术的出现使宠物主人更容易获得高品质的兽医护理,进一步推动了对传染病诊断的需求。
技术进步
根据市场概况,由于技术的快速进步,兽医传染病诊断的需求量很大。诊断的改进大大提高了结果的效率和准确性,这进一步推动了市场的成长。此外,旨在改善动物传染病检测和识别的分子诊断技术(例如聚合酶链反应(PCR))的引入也促进了市场成长。除此之外,自动化分析仪和远距医疗平台等数位健康工具的结合简化了诊断过程,这进一步支持了市场成长。
IMARC Group提供了每个细分市场的主要趋势分析,以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据技术、动物类型、感染类型和最终用户对市场进行了分类。
免疫诊断
分子诊断
其他的
免疫诊断占大部分市场份额
该报告基于该技术对市场进行了详细的细分和分析。这包括免疫诊断、分子诊断等。根据该报告,免疫诊断占最大的部分。
根据兽医传染病诊断市场研究报告,由于对准确疾病检测的需求不断增加,免疫诊断领域占据最大的市场份额。免疫诊断测试,包括酵素连结免疫吸附测定 (ELISA) 和免疫萤光测定 (IFA),对于特异性检测与传染病相关的抗体或抗原的能力至关重要。这种精确度对于早期识别病原体和诊断疾病至关重要,这对于有效治疗和疾病管理至关重要。随着兽医护理变得越来越复杂,人们越来越期望能够快速提供明确结果的高度可靠的诊断工具。宠物和牲畜传染病的发生率不断上升,增加了对此类准确诊断解决方案的需求。
伴侣动物
食品生产动物
伴侣动物占据产业最大份额
报告中还根据动物类型提供了详细的市场区隔和分析。这包括伴侣动物和食用动物。报告称,伴侣动物占据了最大的市场。
兽医传染病诊断市场中的伴侣动物细分市场是由对宠物健康和保健的关注以及诊断技术的进步所推动的。此外,宠物主人越来越重视早期疾病检测,他们更加意识到主动健康管理的好处,正在推动市场成长。这种认知的提高导致对诊断服务的需求不断增长,这些服务可以在疾病变得严重之前识别出疾病,从而为宠物带来更好的健康结果。该细分市场也受到先进诊断工具可用性的推动,例如分子分析和快速护理点测试,这些工具可提供准确、及时的结果。这些创新使兽医能够更有效地诊断和治疗感染,从而提高伴侣动物的整体护理品质。
细菌感染
病毒感染
寄生虫感染
其他的
细菌感染是主要的细分市场
该报告根据感染类型对市场进行了详细的细分和分析。这包括细菌感染、病毒感染、寄生虫感染等。根据该报告,细菌感染占最大部分。
兽医传染病诊断市场的细菌感染部分是由动物细菌性疾病的快速流行所推动的,这需要先进的诊断工具来进行有效的管理和控制。宠物和牲畜中钩端螺旋体病、结核病和沙门氏菌等细菌感染的发生率不断上升,推动了对精确诊断解决方案的需求。人们越来越认识到细菌性疾病对动物健康和生产力的影响,这也推动了对可靠诊断方法的需求,以确保早期发现和介入。此外,该领域的发展受到食品安全焦点转移的推动,因为牲畜的细菌感染可能导致食品供应污染,从而引发严格的测试和监测要求。兽医医疗基础设施和服务的扩展,特别是在新兴经济体,透过增加诊断技术的取得来支持该领域的成长。
参考实验室
兽医实验室和诊所
护理点/内部测试
科学研究院所和大学
参考实验室主导市场
该报告提供了基于最终用户的详细市场细分和分析。这包括参考实验室、兽医实验室和诊所、护理点/内部测试以及研究机构和大学。根据该报告,参考实验室代表了最大的部分。
兽医传染病诊断市场的参考实验室部分是由诊断测试要求日益复杂性所推动的。随着兽医诊断变得越来越复杂,参考实验室的先进能力和专业知识越来越受到依赖。此细分市场的推动因素是对准确、全面的诊断测试的需求不断增长,这些测试可以区分各种病原体和疾病。这种复杂性需要使用高度专业化的设备和熟练的人员,这是参考实验室的标誌。此外,该细分市场受益于需要彻底和高解析度分析的诊断样本量的增加,进一步强调了对参考实验室的需求。对分子诊断和基因组分析等先进测试方法的需求不断增长,推动了对能够高精度进行这些测试的专业参考实验室的需求。
北美洲
美国
加拿大
亚太
中国
日本
印度
韩国
澳洲
印尼
其他的
欧洲
德国
法国
英国
义大利
西班牙
俄罗斯
其他的
拉丁美洲
巴西
墨西哥
其他的
中东和非洲
北美市场领先,占据最大的兽医传染病诊断市场份额
该报告还对所有主要区域市场进行了全面分析,其中包括北美(美国和加拿大);亚太地区(中国、日本、印度、韩国、澳洲、印尼等);欧洲(德国、法国、英国、义大利、西班牙、俄罗斯等);拉丁美洲(巴西、墨西哥等);以及中东和非洲。报告称,北美是兽医传染病诊断的最大区域市场。
北美兽医传染病诊断市场是由宠物和牲畜传染病日益普及所推动的。该地区犬瘟热、猫白血病和各种人畜共通感染等疾病的发生率不断上升,凸显了对有效诊断解决方案的需求。宠物主人对早期发现和预防疾病重要性的认识不断提高,也推动了该区域市场的发展。北美的宠物主人对宠物的健康更加了解和主动,这刺激了对先进诊断服务的需求。此外,兽医诊断技术的快速进步,包括分子生物学、快速检测方法和自动分析仪的创新,正在支持市场的成长。这些进步提高了诊断过程的准确性、速度和效率。除此之外,在私营和公共部门大量投资的支持下,兽医研究和开发(R&D)的日益关注推动了市场的发展。
市场研究报告也对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。兽医传染病诊断行业的一些主要市场参与者包括 Abbott Laboratories、Biomerieux SA、Creative Diagnostics、HESKA Corporation、Innovative Diagnostics、IDEXX Laboratories Inc.、Neogen Corporation、Qiagen NV、Randox Laboratories Ltd、Thermo Fisher Scientific Inc、Viac 。 ETC。
(请注意,这只是关键参与者的部分列表,报告中提供了完整列表。)
市场上一些主要的兽医传染病诊断公司正在积极参与多项策略性倡议,以保持竞争优势并推动市场成长。这些公司专注于广泛的研发,以创新和增强诊断技术。透过大力投资研发,他们的目标是引入先进的诊断工具,例如分子测定和快速检测设备,以提高检测传染病的准确性和速度。与研究机构和学术组织的合作也是一个优先事项,促进尖端技术和解决方案的发展。此外,这些参与者正在透过策略性收购和合作伙伴关係扩大其产品组合,使他们能够提供更广泛的诊断解决方案并进入新市场。他们还正在增强製造能力,以满足对高品质诊断产品不断增长的需求。主要参与者还采用数位技术和资料分析来改善诊断流程,并提供可提供即时结果和预测见解的整合解决方案。
2023 年,IDEXX 实验室推出了一项开创性的兽医诊断测试,用于检测猫和狗的肾臟损伤。该测试是同类测试中的首次,是 IDEXX 策略的一部分,该策略旨在透过先进的诊断解决方案扩展其产品组合,以满足兽医护理中未满足的需求。新测试预计将显着改善宠物的早期诊断和治疗结果,提高它们的生活品质并延长寿命。
2023 年,玛氏收购了 HESKA Corporation,将 HESKA 整合到玛氏宠物护理的科学与诊断部门,从而显着拓宽了先进诊断技术的获取范围并加速了研发计划。此次收购预计将增强 HESKA 为全球兽医专业人士提供全面诊断解决方案的能力,包括现场诊断、远距医疗和创新技术。
2024 年,Neogen Corporation 推出了 SureKill Gel Bait Pro Applicator,扩大了其产品线。 SureKill 系列的这项新产品旨在增强害虫防治解决方案,特别是在动物健康优先的环境中。该喷药器旨在提供高效且有效的害虫防治,确保牲畜和宠物拥有更安全、更健康的条件。
The global veterinary infectious disease diagnostics market size reached US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032. Increasing disease prevalence in pets and livestock, rising pet owner awareness, surging technological advancements, the need for accurate diagnostics, adoption of advanced tools, heightened pet health concerns, expanding veterinary infrastructure, government initiatives for zoonotic disease prevention, and enhanced research funding are factors fueling the market growth.
Major Market Drivers: Globally, the rising prevalence of zoonotic diseases is significantly increasing the demand for advanced diagnostic solutions, creating a positive outlook for the market. Additionally, increasing government initiatives and funding for animal healthcare is driving the veterinary infectious disease diagnostics market growth. Moreover, the expansion of livestock industry and escalating initiatives by major players for conducting research and development (R&D) activity is propelling the market growth. Additionally, increasing utilization of point-of-care (POC) diagnostics, burgeoning telemedicine usage for veterinary care, and growing consumer awareness about animal welfare and quality standards are further boosting the veterinary infectious disease diagnostics demand.
Key Market Trends: The shifting preference toward molecular diagnostics due to their superior sensitivity and specificity is one of the primary market trends. Moreover, the surging use of clustered regularly interspaced short palindromic repeats (CRISPR) for diagnostics as it can be operated on-site is another factor facilitating the market growth. Additionally, the rising integration of artificial intelligence (AI) and machine learning (ML), especially in diagnostic tools, to produce more accurate results is fostering a positive veterinary infectious disease diagnostics market outlook. In line with this, the increasing demand for companion animals and the gradual shift towards multiplex diagnostic assays that detect a variety of pathogens at the same time are fueling the market growth. Furthermore, the collaborations between veterinary practices and diagnostic laboratories and burgeoning demand for point-of-care (POC) diagnostic solutions are driving the market forward.
Geographical Trends: As per the veterinary infectious disease diagnostics market forecast, North America leads the market due to the presence of advance healthcare infrastructure, along with growing number pet ownership and burgeoning investment in animal health. Moreover, the increasing focus on research and development (R&D) by key players and favorable government policies are supporting the regional market growth. Europe holds a considerable share in the market due to stringent animal health regulations and the presence of a number of key market players. Furthermore, in Asia Pacific, the growing awareness of animal health, the easy availability of infectious diagnostics, and burgeoning government funding in animal health are accelerating the market growth.
Competitive Landscape: Some of the major market players in the veterinary infectious disease diagnostics industry include Abbott Laboratories, Biomerieux SA, Creative Diagnostics, HESKA Corporation, Innovative Diagnostics, IDEXX Laboratories Inc., Neogen Corporation, Qiagen N.V., Randox Laboratories Ltd, Thermo Fisher Scientific Inc, and Virbac, among many others.
Challenges and Opportunities: As per the veterinary infectious disease diagnostics market report, the burgeoning cost of diagnostic tools is one of the primary factors hindering the market growth. Additionally, regulatory obstacles and complex approval processes are creating various challenges for the market players, which is another factor restraining the market growth. However, the market also offers various opportunities, such as the increasing prevalence of infectious diseases in animals and rising pet ownership are establishing a huge demand for advanced diagnostics. Moreover, rapid developments in technology, including the emergence of convenient and easy-to-use diagnostic devices and the growing concern about veterinary health and welfare are factors providing a considerable boost to the veterinary infectious disease diagnostics market revenue.
Growing Prevalence of Infectious Diseases in Pets and Livestock
Increasing prevalence of infectious diseases among pets and livestock is accelerating the market growth. For instance, feline leukemia virus (FeLV) is one of the most common infectious diseases in cats, affecting between 2-3% of felines in the US and Canada. The risk is further amplified by the surging interactions among pets and humans, which is further escalating the chances of disease transmission. Moreover, the rapid urbanization, changes in animal husbandry practices, and the rising number of diagnosed patients are supporting the market growth. Another factor boosting the veterinary infectious disease diagnostics market value is the burgeoning demand for accurate and timely diagnostics that can assist with efficient control and containment of these diseases.
Increasing Awareness Among Pet Owners
Rising awareness among pet owners about the importance of early disease detection is a crucial factor driving the market growth. With pets being considered integral family members, owners are increasingly prioritizing their health and well-being. This heightened awareness has led to a growing demand for regular health check-ups, preventive measures, and early diagnostic tests. Additionally, the availability of advanced diagnostic tools and technologies has made it easier for pet owners to access high-quality veterinary care, further driving the demand for infectious disease diagnostics.
Technological Advancements
According to the market overview, veterinary infectious disease diagnostics are witnessing considerably demand due to rapid technological advancements. Improvements in diagnostic have greatly improved the efficiency and accuracy of the results, which is further fueling the market growth. Furthermore, the introduction of molecular diagnostic technologies, such as polymerase chain reaction (PCR), designed to improve detection and identification in animal infectious diseases is facilitating the market growth. Apart from this, the incorporation of digital health tools, such as automated analyzers and telemedicine platforms, have simplified the diagnostics process, which is further supporting the market growth.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on technology, animal type, infection type and end user.
Immunodiagnostics
Molecular Diagnostics
Others
Immunodiagnostics accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the technology. This includes immunodiagnostics, molecular diagnostics, and others. According to the report, immunodiagnostics represented the largest segment.
According to the veterinary infectious disease diagnostics market research report, the immunodiagnostics segment holds the largest market share due to the increasing demand for accurate disease detection. Immunodiagnostic tests, including enzyme-linked immunosorbent assays (ELISA) and immunofluorescence assays (IFA), are essential for their ability to specifically detect antibodies or antigens related to infectious diseases. This precision is critical in identifying pathogens and diagnosing diseases at early stages, which is crucial for effective treatment and disease management. As veterinary care becomes more sophisticated, there is a growing expectation for highly reliable diagnostic tools that can provide definitive results quickly. The escalating prevalence of infectious diseases in pets and livestock has heightened the need for such accurate diagnostic solutions.
Companion Animals
Food Producing Animals
Companion animals holds the largest share of the industry
A detailed breakup and analysis of the market based on the animal type have also been provided in the report. This includes companion animals and food producing animals. According to the report, companion animals accounted for the largest market share.
The companion animals segment in the veterinary infectious disease diagnostics market is driven by the focus on pet health and wellness, as well as advancements in diagnostic technology. Furthermore, the increasing prioritization of early disease detection by pet owners, who are more aware of the benefits of proactive health management are driving the market growth. This heightened awareness results in a growing demand for diagnostic services that can identify diseases before they become severe, leading to better health outcomes for pets. The segment is also driven by the availability of advanced diagnostic tools, such as molecular assays and rapid point-of-care tests, which offer accurate and timely results. These innovations enable veterinarians to diagnose and treat infections more effectively, enhancing the overall quality of care for companion animals.
Bacterial Infections
Viral Infections
Parasitic Infections
Others
Bacterial infections represent the leading market segment
The report has provided a detailed breakup and analysis of the market based on the infection type. This includes bacterial infections, viral infections, parasitic infections, and others. According to the report, bacterial infections represented the largest segment.
The bacterial infections segment in the veterinary infectious disease diagnostics market is driven by the burgeoning prevalence of bacterial diseases among animals, which necessitates advanced diagnostic tools for effective management and control. The rising incidence of bacterial infections such as leptospirosis, tuberculosis, and salmonella in both pets and livestock fuels demand for precise diagnostic solutions. The growing awareness of the impact of bacterial diseases on animal health and productivity also drives the need for robust diagnostic methods to ensure early detection and intervention. Additionally, the segment is driven by the shifting focus on food safety, as bacterial infections in livestock can lead to contamination of the food supply, prompting stringent testing and monitoring requirements. The expansion of veterinary healthcare infrastructure and services, particularly in emerging economies, supports the growth of this segment by enhancing access to diagnostic technologies.
Reference Laboratories
Veterinary Laboratories and Clinics
Point of Care/In House Testing
Research Institutes and Universities
Reference laboratories dominates the market
The report has provided a detailed breakup and analysis of the market based on the end user. This includes reference laboratories, veterinary laboratories and clinics, point of care/in house testing, and research institutes and universities. According to the report, reference laboratories represented the largest segment.
The reference laboratories segment in the veterinary infectious disease diagnostics market is driven by the escalating complexity of diagnostic testing requirements. As veterinary diagnostics become more sophisticated, reference laboratories are increasingly relied upon for their advanced capabilities and specialized expertise. The segment is driven by the surging need for accurate and comprehensive diagnostic tests that can differentiate between various pathogens and diseases. This complexity necessitates the use of highly specialized equipment and skilled personnel, which are hallmarks of reference laboratories. Additionally, the segment benefits from the increasing volume of diagnostic samples that require thorough and high-resolution analysis, further underscoring the need for reference laboratories. The rising demand for advanced testing methods, such as molecular diagnostics and genomic analysis, drives the need for specialized reference laboratories capable of conducting these tests with high precision.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America leads the market, accounting for the largest veterinary infectious disease diagnostics market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for veterinary infectious disease diagnostics.
The North American veterinary infectious disease diagnostics market is driven by the growing prevalence of infectious diseases among pets and livestock. The rising incidence of diseases such as canine distemper, feline leukemia, and various zoonotic infections in the region underscores the need for effective diagnostic solutions. The regional market is also driven by the burgeoning awareness among pet owners about the importance of early detection and prevention of diseases. Pet owners in North America are more informed and proactive about their pets' health, which fuels demand for advanced diagnostic services. Moreover, the surging technological advancements in veterinary diagnostics, including innovations in molecular biology, rapid testing methods, and automated analyzers, are supporting the market growth. These advancements enhance the accuracy, speed, and efficiency of diagnostic processes. Apart from this, the market is driven by the escalating focus on veterinary research and development (R&D), supported by substantial investments from both private and public sectors.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the veterinary infectious disease diagnostics industry include Abbott Laboratories, Biomerieux SA, Creative Diagnostics, HESKA Corporation, Innovative Diagnostics, IDEXX Laboratories Inc., Neogen Corporation, Qiagen N.V., Randox Laboratories Ltd, Thermo Fisher Scientific Inc, Virbac., etc.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Some of the key veterinary infectious disease diagnostics companies in the market are actively engaged in several strategic initiatives to maintain their competitive edge and drive market growth. These companies are focusing on extensive R&D to innovate and enhance diagnostic technologies. By investing heavily in R&D, they aim to introduce advanced diagnostic tools, such as molecular assays and rapid testing devices, that offer greater accuracy and speed in detecting infectious diseases. Collaboration with research institutions and academic organizations is also a priority, facilitating the development of cutting-edge technologies and solutions. Additionally, these players are expanding their product portfolios through strategic acquisitions and partnerships, enabling them to offer a broader range of diagnostic solutions and enter new markets. They are also enhancing their manufacturing capabilities to meet the growing demand for high-quality diagnostic products. Key players are also adopting digital technologies and data analytics to improve diagnostic processes and provide integrated solutions that offer real-time results and predictive insights.
In 2023, IDEXX Laboratories introduced a pioneering veterinary diagnostic test to detect kidney injury in cats and dogs. This test, which is the first of its kind, is part of IDEXX's strategy to expand its portfolio with advanced diagnostic solutions that address unmet needs in veterinary care. The new test is expected to significantly improve early diagnosis and treatment outcomes for pets, enhancing their quality of life and extending lifespans.
In 2023, Mars acquired HESKA Corporation to integrate HESKA into Mars Petcare's Science & Diagnostics division, significantly broadening access to advanced diagnostic technologies and accelerating research and development initiatives. This acquisition is expected to enhance HESKA's capabilities in delivering comprehensive diagnostic solutions, including point-of-care diagnostics, telemedicine, and innovative technologies for veterinary professionals globally.
In 2024, Neogen Corporation expanded its product line with the introduction of the SureKill Gel Bait Pro Applicator. This new addition to the SureKill line aims to enhance pest control solutions, particularly in environments where animal health is a priority. The applicator is designed to provide efficient and effective pest control, ensuring safer and healthier conditions for livestock and pets.